2018 ACAAI/AAAAI Joint Board Certification Review Course

Nashville, TN US
May 18, 2018 to May 20, 2018

Online content now available for registrants. Access by clicking the "Take Course" tab in the middle of the screen.

On behalf of the 2018 Course Co-Chairs, David A. Khan, MD and Thomas A. Fleisher, MD, we invite you to join us a the 2018 ACAAI/AAAAI Joint Board Certification Review Course that will be held at the Nashville Marriott at Vanderbilt University from May 18-20, 2018. We believe you will find this course to be a valuable resource in preparation for the upcoming certification exam as well as for planning future strategies in practice. We believe that you will enjoy the challenge of this intensive program as well as the opportunity to interact with leading experts in the field of allergy and immunology.

The 2018 course is designed as a blended learning experience so that we can maximize the time you are onsite. A portion of the content will be posted online prior to the meeting to be utilized at your convenience. Also, in an effort to keep the cost of the meeting affordable, we will be providing an electronic syllabus only (no print piece). Of course, should you choose to, you can print the syllabus pdf at your own cost. 

Download the Program Schedule for the course. 

Read the Frequently Asked Questions about the course.

Fellows-in-Training: $375 (be sure to check the box for FIT pricing when you register)
Non-FIT: $650

Seating is limited! Enroll now – very few seats remaining.
Onsite registration will not be available for this course.

Reserve your room at the Nashville Marriott at Vanderbilt University now! Limited rooms available at the ACAAI/AAAAI special room rate of $229 per night (excluding tax & fees). Click on this link to obtain the special room rate: https://aws.passkey.com/e/49452721

Note: The group rate is no longer available. Regular priced rooms may still be available.

Target Audience

Fellows-in-Training preparing for upcoming certification exams
Practicing Allergists looking for an intensive review of the key principles in allergy/immunology

Learning Objectives

At the conclusion of this course, participants should be able to:

  • Identify, evaluate and manage current concerns and issues related to the pathophysiology, diagnosis and treatment of allergic and immunologic diseases.
  • Demonstrate a mastery of key concepts in allergy and immunology.
  • Summarize the practical application of key concepts in allergy and immunology in the management of clinical problems.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 18.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
There is no commercial support for this activity.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

All identified conflicts of interest have been resolved.

David Khan, MD, Co-Chair, Planner, Reviewer, Speaker
Data Safety Monitoring Committee, Honorarium: Aimmune
Speaker, Honorarium: Genentech

Mark Ballow, MD, Speaker
Advisory Board, Honorarium: CSL Behring, Shire
Data Safety Monitoring Board, Fees: CSL Behring, Green Cross, Prometic
Speaker, Honorarium: CSL Behring, Shire

Carla Davis, MD, Speaker
Advisory Board, Research Funding: Aimmune Therapeutics
Research, Research Funding: Aimmune Therapeutics, DBV, Nutricia North America

David Lang, MD, Planner, Reviewer, Speaker
Consultant, Fees: Genentech/Novartis, Hycor
Independent Contractor (Topic Editor), Fees: Dynamed
Research, Research Funding: Genentech/Novartis
Speaker, Honorarium: AstraZeneca, Genentech/Novartis

Carol Langford, MD, MHS, Speaker
Research, Research Funding: Bristol Myers Squibb, ChemoCentryx, Genentech, GlaxoSmithKline

Jordan Orange, MD, PhD, Speaker
Advisory Board, Fees: ADMA Biologics
Consultant, Fees: CSL Behring, Shire
Speaker, Honorarium: Shire

Anju Peters, MD, Speaker
Advisory Board, Honorarium: Optinose, Sanofi
Research, Research Funding: AstraZeneca, Sanofi
Speaker, Honorarium: Greer

John Routes, MD, Planner, Reviewer, Speaker
Research, Research Funding: CSL Behring

Troy Torgerson, MD, Speaker
Consultant, Fees: ADMA Biosciences, CSL Behring, Shire, UCB Biopharmaceuticals
Research, Research Funding: CSL Behring, Shire

The following have no financial relationships to disclose:
Thomas Fleisher, MD, Co-Chair, Planner, Reviewer, Speaker
Karyl Barron, MD, Speaker

Anthony Gaspari, MD, Speaker
Matthew Giannetti, MD, Speaker

Steven Holland, MD, Speaker
Paneez Khoury, MD, Speaker
Sergio Rosenzweig, MD, Speaker
Mark Sands, MD, Speaker
Robert Schleimer, PhD, Speaker

Joseph Spahn, MD, Speaker
Kelly Stone, MD, PhD, Planner, Reviewer, Speaker
Kate Sullivan, MD, Planner, Reviewer

Mike Tankersley, MD, Speaker
J. Tom Thomas, II, MD, Speaker

Cancellations:

You may receive a refund (minus $75 administration fee) if your cancellation request is received via email (marycampbell@acaai.org) on or before April 20, 2018. Cancellations requests received after April 20 are not eligible for a refund. The College is not responsible for hotel cancellations. Please contact the Marriott at (615) 321-1300.

Course summary
Available credit: 
  • 18.50 AMA PRA Category 1 Credit™
  • 18.50 Attendance
Course opens: 
10/01/2017
Course expires: 
07/31/2019
Event starts: 
05/18/2018 - 7:30am
Event ends: 
05/20/2018 - 12:30pm
Cost:
$650.00
Nashville Marriott at Vanderbilt University
2555 West End Avenue
Nashville, TN 37203
United States
+1 (615) 321-1300

Enjoy the convenience and savings of staying on property at the Nashville Marriott at Vanderbilt University in the ACAAI/AAAAI room block. To take advantage of the special room rate of only $229 per night (excluding tax & fees), please make your hotel reservation by Monday, April 16, 2018. Any reservations made after this date cannot be guaranteed at the ACAAI/AAAAI room rate, nor can we guarantee hotel availability.

Reserve your room now!
https://aws.passkey.com/e/49452721

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 18.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
There is no commercial support for this activity.

Available Credit

  • 18.50 AMA PRA Category 1 Credit™
  • 18.50 Attendance

Accreditation Period

Course opens: 
10/01/2017
Course expires: 
07/31/2019

Price

Cost:
$650.00
Please login or create an account to take this course.